Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis. McKinzie CJ, Kam CW, Jones MC, Gifford LB, et al. Pediatr Pulmonol 2024;59:1795-1797.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McKinzie CJ, Kam CW, Jones MC, Gifford LB, et al. Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis. Pediatr Pulmonol 2024;59:1795-1797.
PMID: 38517044